Wolverine Trading, LLC Aerie Pharmaceuticals Inc Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$17.72 - $25.1 $430,773 - $610,181	-24,310 Reduced 73.79%	8,637 $200,000
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $243,564 - $370,440	13,230 Added 67.1%	32,947 $670,000
Q2 2019 Aug 20, 2019	BUY	$28.97 - $48.21 $88,503 - $147,281	3,055 Added 18.34%	19,717 $583,000
Q1 2019 May 15, 2019	BUY	$36.32 - $49.25 $327,061 - $443,496	9,005 Added 117.6%	16,662 $791,000
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $429,940 - $565,852	7,657 New	7,657 $471,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.